GSK could double CEO Emma Walmsley’s pay to $27 million in bid to bring U.K. exec salaries in line with the U.S.
The British pharma giant said Emma Walmsley’s current pay could put off candidates for her eventual successor. Read More
GSK
British pharma giant GSK to acquire U.S. drug developer IDRx in $1.15 billion deal
The biopharmaceutical company’s drug in development is designed to treat gastrointestinal stromal tumors (GIST). Read More
GSK, Pfizer RSV shots must warn about rare paralysis risk
An analysis found nine excess cases of Guillain-Barré for every million doses given. Read More